Abstract
Electrochemotherapy has been proven to be efficient for the treatment of subcutaneous tumors of different histological types in mice, rats and cats (1–3). Electrochemotherapy is essentially a local treatment. Indeed, it is based on the potentiation of the cytotoxicity of a low-permeant drug, typically bleomycin, by tumor cell permeabilization using brief and intense electric pulses. In the tissues exposed to such electric pulses, the so-called cell electropermeabilization is obtained only in the volume crossed by an electric field of intensity higher than a threshold value (4). The existence of this threshold for tissue permeabilization implies that the potentiation of the cytotoxic drug by the applied electric pulses is limited to the space roughly comprised between the electrodes. In the case of rather small and prominent cutaneous or subcutaneous tumors, it is easy to place two external electrodes on each side of the tumor nodule to be treated and to transcutaneously deliver the permeabilizing electric pulses. For thick and for deep subcutaneous tumors as well as for tumors located in internal organs, this electrode configuration is not appropriate because the electric pulses have to be delivered directly to the tumor tissues. Externally placed electrodes simply do not supply electric fields that extend deep enough for these situations. Intratumoral electric pulse delivery can, however, be achieved using needle-electrodes that are inserted into the tumor volume. We have designed an applicator constituted by multiple parallel and equidistant needles in order to avoid the delivery of very high-voltage electric pulses. A specifically manufactured generator ensures the multiplexed supplying of the electric current to each pair of closest needle electrodes. Thus, the entire tumor volume is divided in small units which are separately permeabilized by the different pairs of closest electrodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mir, L. M., Orlowski, S., Belehradek, J. Jr, and Paoletti, C. (1991) Electrochemotherapy: potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer 27, 68–72.
Okino, M., Tomie, H., Kanesada, H., Marumoto, M., Esato, K., and Suzuki, H. (1992) Optimal electric conditions in electrical impulse chemotherapy. Jpn. J. Cancer Res. 83, 1095–1101.
Mir, L. M., Devauchelle, P., Quintin-Colonna, F., Delisle, F., Doliger, S., Fradelizi, D., Belehradek, J. Jr., and Orlowski, S. (1997) First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer 76, 1617–1622.
Belehradek, J. Jr., Orlowski, S., Ramirez, L. H., Pron, G., Poddevin, B., and Mir, L. M. (1994) Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim. Biophys. Acta 1190, 155–163.
Ramirez, L. H., Orlowski, S., An, D. J., Bindoula, G., Dzodic, R., Ardouin, P., Bognel, C., Belehradek, J. Jr., Munck, J. N., and Mir, L. M. (1998) Electrochemotherapy on liver tumours in rabbits. Br. J. Cancer 77, 2104–2111.
Salford, L. G., Persson, B. R. R., Brun, A., Ceberg, C. P., Kongstad, P. C., and Mir, L. M. (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194, 938–943.
Belehradek, M., Domenge, C., Luboinski, B., Orlowski, S., Belehradek, J. Jr., and Mir, L. M. (1993) Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer 72, 3694–3700.
Mir, L. M., Orlowski, S., Poddevin, B., and Belehradek, J. Jr. (1992) Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host’s defenses. Eur. Cytokine Netw. 3, 331–334.
Mir, L. M., Roth, C., Orlowski, S., Quintin-Colonna, F., Fradelizi, D., Belehradek, J. Jr., and Kourilsky, P. (1995) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J. Immunother. 17, 30–38.
Ferrara, P., Pecceu, P., Marchese, E., Vita, N., Roskam, W., and Lupker, J. (1987) Characterization of recombinant glycosylated human interleukin-2 produced by a recombinant plasmid transformed CHO cell line. FEBS Lett. 226, 47–52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Orlowski, S., Mir, L.M. (2000). Treatment of Liver Tumors in Rabbit. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (eds) Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Methods in Molecular Medicine, vol 37. Humana Press. https://doi.org/10.1385/1-59259-080-2:327
Download citation
DOI: https://doi.org/10.1385/1-59259-080-2:327
Publisher Name: Humana Press
Print ISBN: 978-0-89603-606-2
Online ISBN: 978-1-59259-080-3
eBook Packages: Springer Protocols